Hospital Stay Is Not a Direct Measure of Tumor Biology

Authors

  • Leonard Barker Author
  • Stanley Pearson Author
  • Norman Armstrong Author

Abstract

Discharge processes, postoperative care, disease states create distinct evidence obligations in immune-state and tumor evidence synthesis. A bounded review of the literature is used to formulate, rather than claim to complete, an evaluation. The starting source uses a conceptual review proposing immunometabolic set points across immune and tissue compartments. An outcome can reflect both biological condition and organizational practice. Hospital stay, service delay, and review completion are shaped by capacity and rules. Separate event definition from its interpretation. Compare models across process changes and include operational variables where they influence the measured outcome. The proposed comparison concerns discharge processes, postoperative care, disease states; it would test whether the specific failure scenario is detected without erasing legitimate uncertainty. The original source's limits remain material: A unifying set point is a hypothesis, not an already validated clinical measurement or an established therapeutic protocol.

References

  1. Yu, Xiao, et al. “Resetting Immunometabolic Set Points in Autoimmune Disease.” Journal of Translational Autoimmunity, vol. 13, 2026, https://doi.org/10.1016/j.jtauto.2026.100391.
  2. Guo, Qian, et al. “Immune Niches in Brain Tumors: Glial–Immune Cell Interactions and Spatial Microdomains.” Acta Neuropathologica Communications, vol. 14, 2026, https://doi.org/10.1186/s40478-026-02373-0.
  3. Zhang, Yidan, et al. “Splenic Extramedullary Granulopoiesis and Neutrophil States in Cancer Immunity: Systemic Immunosuppression and Therapeutic Resistance.” Cancer Bioscience, 2026, https://doi.org/10.1016/j.cbs.2026.100009.
  4. Gao, Bibo, et al. “The Prediction of Extended Hospital Length of Stay in Patients after Endoscopic Endonasal Transsphenoidal Surgery for the Resection of Non-Functioning Pituitary Adenomas: A Dual-Center Retrospective Analysis.” Cancers, vol. 18, no. 10, 2026, https://doi.org/10.3390/cancers18101582.
  5. Rajkomar, Alvin, Jeffrey Dean, and Isaac Kohane. “Machine Learning in Medicine.” New England Journal of Medicine, vol. 380, 2019, pp. 1347–58.
  6. Wiens, Jenna, et al. “Do No Harm: A Roadmap for Responsible Machine Learning for Health Care.” Nature Medicine, vol. 25, 2019, pp. 1337–40.
  7. Guo, Chuan, et al. “On Calibration of Modern Neural Networks.” Proceedings of the 34th International Conference on Machine Learning, 2017, pp. 1321–30.
  8. Ovadia, Yaniv, et al. “Can You Trust Your Model’s Uncertainty? Evaluating Predictive Uncertainty under Dataset Shift.” Advances in Neural Information Processing Systems, vol. 32, 2019.
  9. Geifman, Yonatan, and Ran El-Yaniv. “Selective Classification for Deep Neural Networks.” Advances in Neural Information Processing Systems, vol. 30, 2017.
  10. Lundberg, Scott M., and Su-In Lee. “A Unified Approach to Interpreting Model Predictions.” Advances in Neural Information Processing Systems, vol. 30, 2017.
  11. World Health Organization. Ethics and Governance of Artificial Intelligence for Health. World Health Organization, 2021.
  12. National Academies of Sciences, Engineering, and Medicine. Reproducibility and Replicability in Science. National Academies Press, 2019.
  13. Wilkinson, Mark D., et al. “The FAIR Guiding Principles for Scientific Data Management and Stewardship.” Scientific Data, vol. 3, 2016, article 160018.
  14. Hernán, Miguel A., and James M. Robins. Causal Inference: What If. Chapman & Hall/CRC, 2020.

Downloads

Published

2026-10-14

Issue

Section

Reviews and Perspectives